School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Acta Biochim Biophys Sin (Shanghai). 2022 Oct 25;54(10):1507-1517. doi: 10.3724/abbs.2022143.
Monocyte chemoattractant protein-1 (MCP-1) plays a crucial role in various inflammatory diseases. To reveal the impact of MCP-1 during diseases and to develop anti-inflammatory agents, we establish a transgenic mouse line. The firefly luciferase gene is incorporated into the mouse genome and driven by the endogenous promoter. A bioluminescence photographing system is applied to monitor luciferase levels in live mice during inflammation, including lipopolysaccharide-induced sepsis, concanavalin A-induced T cell-dependent liver injury, CCl -induced acute hepatitis, and liver fibrosis. The results demonstrate that the luciferase signal induced in inflammatory processes is correlated with endogenous MCP-1 expression in mice. Furthermore, the expressions of and the luciferase gene are dramatically inhibited by administration of the anti-inflammatory drug dexamethasone in a septicemia model. Our results suggest that the transgenic MCP-1-Luc mouse is a useful model to study MCP-1 expression in inflammation and disease and to evaluate the efficiency of anti-inflammatory drugs .
单核细胞趋化蛋白-1(MCP-1)在各种炎症性疾病中起着至关重要的作用。为了揭示 MCP-1 在疾病中的作用并开发抗炎药物,我们建立了一个转基因小鼠品系。萤火虫荧光素酶基因被整合到小鼠基因组中,并由内源性启动子驱动。应用生物发光成像系统监测活体小鼠在炎症过程中的荧光素酶水平,包括脂多糖诱导的败血症、刀豆蛋白 A 诱导的 T 细胞依赖性肝损伤、CCl4 诱导的急性肝炎和肝纤维化。结果表明,在炎症过程中诱导的荧光素酶信号与小鼠内源性 MCP-1 的表达相关。此外,在败血症模型中,抗炎药物地塞米松的给药显著抑制 和荧光素酶基因的表达。我们的结果表明,转基因 MCP-1-Luc 小鼠是研究炎症和疾病中 MCP-1 表达以及评估抗炎药物疗效的有用模型。